• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Christopher M. Whaley, PhD

Latest:

Pricing and Insurance Networks in Outpatient Surgery Markets

This article examines how prices, insurer payments, and patient payments for outpatient surgeries differ by site of care and network status.


William Zafirau, MD

Latest:

High-Intensity Home-Based Rehabilitation in a Medicare Accountable Care Organization

High-intensity home-based rehabilitation (HIHR) may substitute for facility-based postacute rehabilitation. Patients in HIHR had better functional outcomes at lower costs than patients in facility-based care.



Jason D. Wright, MD

Latest:

Cost Sharing for Oral Lenvatinib Among Commercially Insured Patients

Among a cohort of insured patients with cancer, the median total monthly cost of oral lenvatinib was $17,253, and 75% of patients paid $100 or less out of pocket per month for the drug.


Mark K. Meiselbach, PhD

Latest:

Mental Health Care Use After Leaving Medicare Advantage for Traditional Medicare

Medicare Advantage beneficiaries with mental health diagnoses see more nurse practitioners and fewer internal medicine and emergency medicine specialists after switching to traditional Medicare.


Tracy Zvenyach, PhD, NP

Latest:

Assessing Opportunities to Advance Quality Measures in Adult Obesity

Obesity is a serious chronic disease and risk factor for a broad range of outcomes. This study identifies opportunities for improving quality in obesity care.


Jeffrey Fine, MPH

Latest:

Demographic Disparities in Video Visit Telemetry: Understanding Telemedicine Utilization

A stratified demographics analysis of video visit telemetry data reveals that age older than 65 years and African American/Black race are associated with higher video visit failure rates, whereas language, sex, and ethnicity are not.


Gang Luo, PhD

Latest:

Development and Validation of the COVID-19 Hospitalized Patient Deterioration Index

The authors developed and validated an accurate, well-calibrated, easy-to-implement COVID-19 hospitalized patient deterioration index to identify patients at high or low risk of clinical deterioration.


Kelly King

Latest:

KYV-101 Achieves Durable Response in Myasthenia Gravis

KYV-101 shows promising efficacy in treating generalized myasthenia gravis, achieving significant symptom reduction and demonstrating a novel CAR T-cell approach.


Dr Sundar Jagannath | Image Credit: Mount Sinai
Sundar Jagannath, MBBS

Latest:

Linvoseltamab Approval Expands Access, Increases Competition in BCMA Bispecifics Space: Sundar Jagannath, MBBS

Following the FDA approval of linvoseltamab (Lynozyfic; Regeneron) for heavily pretreated multiple myeloma, Sundar Jagannath, MBBS, highlights its potential for earlier use, increased accessibility, and greater competition in the B-cell maturation antigen (BCMA) bispecific antibody space.


Carlos Kerguelen, MD, MA

Latest:

The Impact of Outliers on Available Resources in a Teaching Hospital in Colombia

This letter describes the experience of long-stay patients and provides a perspective of the need for more studies on outliers’ impact on health care.


Sarah Mallik, MD, MA

Latest:

Community Health Workers’ Critical Role in Trust Building Between the Medical System and Communities of Color

The authors interrogate elements of routine medical practice in New York City to argue for reforms of hospital culture through relational trust-building capabilities of community health workers.


Eleena Koep, MS

Latest:

Treatment Modification After Initiating Second-Line Medication for Type 2 Diabetes

Among adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification.


Kym Householder, RN, LAc

Latest:

Improving Pain Clinic Outcomes With Preappointment Surveys: Data-Driven Policy Change

Implementing a policy change to require preappointment surveys before scheduling initial clinic evaluations can improve wait-list times and show rates.


Kyle J. Moon, BS

Latest:

Potential Health Literacy Resources for Health Plans: A Narrative Review

Several evidence-based health literacy resources may be beneficial in health plan settings to improve organizational health literacy, personal health literacy, and health equity.



Ariel Roguin, MD, PhD

Latest:

Predicting Mortality Risk Using the PREVENT Equation Across Diverse Racial Groups

This study validates the Predicting Risk of CVD Events (PREVENT) score across diverse racial and ethnic populations, highlighting its effectiveness in predicting cardiovascular risk and mortality, regardless of race or ethnicity.



Emeline M. Aviki, MD, MBA

Latest:

Cost Sharing for Oral Lenvatinib Among Commercially Insured Patients

Among a cohort of insured patients with cancer, the median total monthly cost of oral lenvatinib was $17,253, and 75% of patients paid $100 or less out of pocket per month for the drug.


Sanne J. Magnan, MD, PhD

Latest:

Integrating Research, Health Care, and Community at Scale to Address the Population Health Question

The authors discuss the need to repair a house divided among research, health care, and the multisector health community.


Gregory Kruse, MSc, MPH

Latest:

Economics of a Health System’s Direct-to-Consumer Telemedicine for Its Employees

A direct-to-consumer telemedicine service resulted in lower per-episode unit costs for care within 7 days and only marginally increased the use of services overall.


Helen Yu-Lefler, DrPH

Latest:

Service Utilization by High-Need, High-Cost Patients Following Emergency Department Visits

This article provides insights into patterns of health care use following emergency department visits by high-need, high-cost patients with different types of California Medicaid primary care providers.


Pam Cowin, PhD, RN

Latest:

Having Someone Who Cares: Patient Perspectives of Care Management Programs

This article presents a single-organization qualitative case description of the perspectives of patients with high-need, high-cost illnesses who participated in care management programs.


Anthony “Nino” Sireci, MD, MSc | Image Credit: © Eli Lilly and Company,
Anthony "Nino" Sireci, MD, MSc

Latest:

Navigating the Alzheimer Disease Blood Test Revolution

A new FDA-approved blood test for Alzheimer disease could transform diagnosis and treatment accessibility, according to this conversation with Howard Fillit, MD, and Anthony “Nino” Sireci, MD, MSc.


Justin Drake, PhD

Latest:

Driving Progress Through Collaboration at SABCS

The San Antonio Breast Cancer Symposium fosters collaboration among experts, enhancing research and treatment strategies for breast cancer's complex landscape.


Laura M. Baum, MURP

Latest:

Changes in Marketplace Competition and Television Advertising by Insurers

This study provides the first evidence on how Marketplace insurers are altering their marketing in response to changes in competitive pressure over time.


Gert Bergman, PhD, MSc

Latest:

Cost Analysis of Self-Monitoring Blood Glucose in Nonintensively Managed Type 2 Diabetes

Analysis of claims data showed reduced utilization and costs among patients with nonintensively managed type 2 diabetes using self-monitoring of blood glucose compared with continuous glucose monitoring.


Tran Thu Doan, PhD, MPH

Latest:

Provision of Telemental Health Before and After COVID-19 Onset

The authors examine the prevalence of telemedicine services provided by mental health care organizations before and after onset of the COVID-19 pandemic in the United States.


Mary C. Frazier, BS

Latest:

A “Sludge Audit” for Health System Colorectal Cancer Screening Services

A systematic, mixed methods “sludge audit” identified novel health system delivery targets for improving colorectal cancer screening services.


Nancy L. Sicotte, MD

Latest:

Linking Data to Determine Risk for 30-Day Readmissions in Dementia

This study found that certain characteristics in linked electronic health record data across episodes of care can help identify patients with Alzheimer disease and related dementias at high risk of 30-day readmissions.

© 2025 MJH Life Sciences
AJMC®
All rights reserved.